Pablizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pablizumab, covering 2021-07-20 to 2021-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy [Phase 2, Phase 3]